Enablex
Enablex is a bladder medication containing Darifenacin, available as 7.5mg tablets.
- Category
- Bladder
- Active ingredient
- Darifenacin
- Route
- Oral use
- Form
- Prolonged-release tablet
- Strengths
- 7.5mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Enablex vary by country.
Details
- Conditions
- Overactive bladder
- Alternative Name
- Dartel
- Therapeutic Class
- Antimuscarinic
- Pharmacological Class
- Muscarinic Receptor Antagonist
- Minor Side Effects
- dry mouth, constipation
- Moderate Side Effects
- dyspepsia, abdominal pain, urinary tract infection
- Dosage Forms
- Prolonged-release tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Originator
- Novartis
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage Instructions
- Store below 25°C.
- Drug Interactions
- strong CYP3A4 inhibitors
- Age Restrictions
- Not for use in children.
What you will receive
Enablex is the originator brand name, made by Novartis. We use it here to identify the medicine only; we are not affiliated with Novartis and do not ship the original Enablex.
- You receive a generic equivalent: the same active ingredient (Darifenacin) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.